Unloxcyt
Payments companies reported to CMS as associated with Unloxcyt. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Unloxcyt, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Unloxcyt
These are the largest totals companies reported as associated with Unloxcyt. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ann Silk | Boston, MA | Medical Oncology | $27,668.86 |
| David Miller | Boston, MA | Dermatology | $23,958.17 |
| Michael Migden | Houston, TX | Dermatology | $19,774.80 |
| Emily Ruiz | Boston, MA | Dermatology | $19,648.27 |
| Brent Moody | Nashville, TN | Mohs-Micrographic Surgery | $19,428.35 |
| Nikhil Khushalani | Buffalo, NY | Medical Oncology | $19,059.26 |
| Vishal Patel | Leesburg, VA | Dermatology | $15,642.21 |
| Scott Dinehart | Little Rock, AR | Mohs-Micrographic Surgery | $13,813.06 |
| Todd Schlesinger | Charleston, SC | Dermatology | $13,063.10 |
| Janice Mehnert | New York, NY | Medical Oncology | $11,711.08 |
Prescribed Unloxcyt?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.